tirzepatide vs semaglutide differences efficacy safety Tirzepatide: Head-to-Head for Weight Loss & Diabetes Tirzepatide vs. Ozempic: Comparing Diabetes
Description
Tirzepatide is a dual incretin receptor agonist, meaning it activates both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor
SU, sulphonylurea
Expect to see oral doses in the hundreds of milligrams to achieve what injectable doses accomplish in single-digit milligrams
Nausea increases with dose, as expected, but the slope is gentler than with semaglutide
